Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact Leave a Comment / By Leonardo Arias / 07/01/2026 Cartography will hunt for novel tumor antigens, which Pfizer can opt into and advance into clinical development.
